Provided By GlobeNewswire
Last update: May 14, 2025
Q1 Net Revenue Increased 26% Year-Over-Year
FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the first quarter ended March 31, 2025.
Read more at globenewswire.com29.68
-0.72 (-2.37%)
Find more stocks in the Stock Screener